Dr Daniel C. Chung appointed as Chief Medical Officer of SparingVision
Dr Daniel C. Chung appointed as Chief Medical Officer of SparingVision Former Spark Therapeutics head…
Month: February 2021
Dr Daniel C. Chung appointed as Chief Medical Officer of SparingVision
Dr Daniel C. Chung appointed as Chief Medical Officer of SparingVision Former Spark Therapeutics head…
argenx announces full exercise of underwriters’ option to purchase additional ADSs
Regulated information — Inside information February 4, 2021 Breda, the Netherlands — argenx SE (Euronext &…
Roche reports solid results in 2020
Basel, 4 February 2021 Group sales increase 1%1 at constant exchange rates (CER); 5% decline…
Issue of Equity on Exercise of Options/Vesting of Performance Share Awards
Acacia Pharma Group plc Issue of Equity on Exercise of Options/Vesting of Performance Share Awards…
Idorsia announces financial results for 2020 – a successful year marked by outstanding clinical data
Allschwil, Switzerland – February 4, 2021 Idorsia Ltd (SIX: IDIA) today announced its financial results…
Iterum Therapeutics plc Increases Previously Announced Bought Deal Public Offering of Ordinary Shares to $40.0 Million
DUBLIN, Ireland and CHICAGO, Feb. 03, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM)…
Revolution Medicines Announces Pricing of Upsized $260.9 Million Public Offering of Common Stock
REDWOOD CITY, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) — Revolution Medicines, Inc. (Nasdaq: RVMD) today…
Sana Announces Upsized Pricing of Initial Public Offering
SEATTLE, Feb. 03, 2021 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (Sana) (Nasdaq: SANA), a company…
Novavax and Government of Switzerland Announce Agreement in Principle to Supply COVID-19 Vaccine
Switzerland to purchase six million doses of the Novavax vaccine candidate, NVX-CoV2373 GAITHERSBURG, Md., Feb….
Sensei Biotherapeutics Announces Pricing of Upsized Initial Public Offering
BOSTON and ROCKVILLE, Md., Feb. 03, 2021 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc., a clinical-stage…
Landos Biopharma Announces Pricing of Initial Public Offering
BLACKSBURG, Va., Feb. 03, 2021 (GLOBE NEWSWIRE) — Landos Biopharma, a clinical-stage biopharmaceutical company focused…
Iterum Therapeutics plc Announces $10 Million Bought Deal Public Offering of Ordinary Shares
DUBLIN, Ireland and CHICAGO, Feb. 03, 2021 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM)…
Psyence Group Presenting at Canaccord Genuity Conference “New Paradigms & Treatment Approaches in Mental Health”
TORONTO, Feb. 03, 2021 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE: PSYG) (“Psyence” or the…
Rubius Therapeutics to Participate in Guggenheim Healthcare Talks | 2021 Oncology Days
CAMBRIDGE, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage…
ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 03, 2021 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals,…
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
LEXINGTON, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) — Translate Bio (Nasdaq: TBIO), a clinical-stage messenger…
Codexis Appoints Dr. Esther Martinborough to its Board of Directors
REDWOOD CITY, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq:CDXS), a leading enzyme…
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
BOSTON, Feb. 03, 2021 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company…
Assertio Announces $5.0 Million Insurance Settlement and General Corporate Updates
LAKE FOREST, Ill., Feb. 03, 2021 (GLOBE NEWSWIRE) — Assertio Holdings, Inc. (“Assertio” or the…